Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Seval, Erhamamci"'
Publikováno v:
Molecular Imaging and Radionuclide Therapy. 30:119-121
Childhood malignant melanoma (MM) is extremely uncommon. We report an unusual case of cutaneous melanoma that developed from a medium-sized congenital melanocytic nevus (CMN) in a two-year-old girl. The patient had a history of CMN on the right hip,
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular. 39:383-386
Publikováno v:
Volume: 3, Issue: 4 487-489
Journal of Health Sciences and Medicine
Journal of Health Sciences and Medicine
We present in a 67-year-old woman with multisystem sarcoidosis on 18F-FDG PET/CT
Autor:
Seval, Erhamamci, Nesrin, Aslan
Publikováno v:
Revista espanola de medicina nuclear e imagen molecular. 40(2)
Autor:
Seval Erhamamci, Nesrin Aslan
Publikováno v:
Clinical nuclear medicine. 45(3)
Ga-PSMA PET/CT imaging is an emerging imaging modality in prostate cancer. PSMA expression is also reported for nonprostate malignancies, including primary hepatocellular carcinoma. Herein, we present a case of a 74-year-ald man with recently diagnos
Autor:
Nesrin Aslan, Seval Erhamamci
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular. 40:186-187
Autor:
Nesrin Aslan, Seval Erhamamci
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 40:186-187
Publikováno v:
Revista espanola de medicina nuclear e imagen molecular. 39(6)
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular. 34:287-294
Objective Clinical data are presented on patients with tumor thrombosis (TT) incidentally detected on FDG PET/CT imaging, as well as determining its prevalence and metabolic characteristics. Materials and methods Out of 12,500 consecutive PET/CT exam
Publikováno v:
Molecular Imaging and Radionuclide Therapy, Vol 23, Iss 2, Pp 43-47 (2014)
Molecular Imaging and Radionuclide Therapy
Molecular Imaging and Radionuclide Therapy
Interferon-beta (IFN-β) is widely used in patients with multiple sclerosis (MS), a demyelinating disease of the central nervous system. High incidence of thyroid dysfunction has been reported after administration of IFN-β in MS patients. The aim of